Search Results - "Fay, Andre Poisl"
-
1
The Impact of Fibroblast Growth Factor Receptor Alterations in Clinical Outcomes of Patients With Advanced Urothelial Carcinoma: Real-World Data From a Latin American Population
Published in Clinical genitourinary cancer (01-10-2024)“…•The largest study to evaluate the prevalence of FGFR alterations in patients with mUC in LATAM patients.•The prevalence of FGFR alterations in patients with…”
Get full text
Journal Article -
2
The impact of a breast cancer diagnosis on marital outcomes and factors associated with divorce and separation
Published in Revista Brasileira de ginecologia e obstetrícia (01-01-2024)“…To analyze marital outcomes, divorce or separation, and its association with demographic, socioeconomic, and clinicopathological factors among breast cancer…”
Get full text
Journal Article -
3
Core Needle Biopsy Accuracy for Androgen Receptor Expression in Invasive Breast Cancer
Published in Revista Brasileira de ginecologia e obstetrícia (01-09-2023)“…Objective Breast cancer (BC) biomarkers, such as hormone receptors expression, are crucial to guide therapy in BC patients. Antiandrogens have been studied in…”
Get full text
Journal Article -
4
The role of 68Gallium-prostate-specific membrane antigen positron emission tomography on staging of high-risk localized prostate cancer: for all high-risk patients or would it be better to select them?
Published in Prostate international (01-03-2021)“…According to pathologico-clinical features, patients diagnosed with localized prostate cancer (PCa) are stratified into distinct risk groups (low-risk,…”
Get full text
Journal Article -
5
Rapid and low-cost liquid biopsy with ATR-FTIR spectroscopy to discriminate the molecular subtypes of breast cancer
Published in Talanta (Oxford) (01-03-2023)“…Breast cancer (BC) is the most prevalent cancer worldwide. The prognosis and survival of these patients are directly related to the diagnostic stage. Even so,…”
Get full text
Journal Article -
6
Discrimination of molecular subtypes of breast cancer with ATR-FTIR spectroscopy in blood plasma coupled with partial least square-artificial neural network discriminant analysis (PLS-ANNDA)
Published in Chemometrics and intelligent laboratory systems (15-06-2023)“…Attenuated total reflection-Fourier transform infrared (ATR-FTIR) spectroscopy is a simple, rapid, reagent-free, and non-invasive technique that was used as…”
Get full text
Journal Article -
7
The impact of preoperative immune checkpoint inhibitors on kidney and bladder cancer surgeries: a systematic review
Published in Current problems in cancer (01-02-2022)“…Therapies based on the use of immune checkpoint inhibitors (ICIs), such as nivolumab, pembrolizumab, ipilimumab, atezolizumab, avelumab, and durvalumab, have…”
Get full text
Journal Article -
8
Sparing chemotherapy with dual HER2 blockade in combination with endocrine therapy for advanced HER2 positive breast cancer
Published in Translational cancer research (01-06-2018)Get full text
Journal Article -
9
Impact of geographic region on overall survival (OS) in patients with metastatic renal cell carcinoma (mRCC): Results from a pooled clinical trials database
Published in Journal of clinical oncology (20-05-2017)“…Abstract only 4583 Background: Health determinants vary according to the geographic region and may impact the outcomes of mRCC patients treated on clinical…”
Get full text
Journal Article -
10
Sex and survival outcomes in patients with renal cell carcinoma receiving first-line immune-based combinations
Published in Cancer Immunology, Immunotherapy : CII (04-06-2024)“…Background There is an ongoing debate as to whether sex could be associated with immune checkpoint inhibitor (ICI) benefit. Existing literature data reveal…”
Get full text
Journal Article -
11
A Systematic Review and Meta-Analysis of the Role of Immune Checkpoint Inhibitors (ICI) as Adjuvant Treatment for Localized High-Risk Muscle-Invasive Urothelial Carcinoma (MIUC)
Published in Clinical genitourinary cancer (01-10-2022)“…•Systemic adjuvant chemotherapy for muscle-invasive bladder carcinoma is controversial.•Systemic adjuvant chemotherapy for muscle-invasive upper tract…”
Get full text
Journal Article -
12
Systemic Immune-Inflammation Index in Patients Treated With First-Line Immune Combinations for Metastatic Renal Cell Carcinoma: Insights From the ARON-1 Study
Published in Clinical genitourinary cancer (01-04-2024)“…•Immune-based combinations are the standard systemic treatment for mRCC.•IMDC prognostic risk score is a prognostic tool developed and validated in the…”
Get full text
Journal Article -
13
Phase II randomized study of abiraterone acetate plus ADT versus apalutamide versus abiraterone and apalutamide in patients with advanced prostate cancer with non-castrate testosterone levels. (LACOG 0415)
Published in Journal of clinical oncology (20-02-2018)“…Abstract only TPS404 Background: Androgen deprivation therapy (ADT) combined with abiraterone (AA) or docetaxel are considered the standard of care (SOC) for…”
Get full text
Journal Article -
14
Impact of primary tumor resection in oligometastatic non-small cell lung cancer: Experience of a resource-limited cancer center in southern Brazil
Published in Journal of clinical oncology (20-05-2017)“…Abstract only e20552 Background: Stage IV non-small cell lung cancer (NSCLC) with low volume disease represents a more indolent phenotype within the biological…”
Get full text
Journal Article -
15
ERCC1 as a prognostic factor for survival in patients with advanced urothelial cancer treated with platinium-based chemotherapy: A systematic review and meta-analysis
Published in Journal of clinical oncology (01-03-2015)“…Abstract only 351 Background: Platinium based chemotherapy (CT) is an essential part in the treatment of advanced urothelial cancer (AUC). However, not all…”
Get full text
Journal Article -
16
Differential side effects profile in mCRPC patients treated with abiraterone or enzalutamide: A meta-analysis of randomized controlled trials
Published in Journal of clinical oncology (10-01-2016)“…Abstract only 73 Background: Abiraterone and enzalutamide are currently approved for mCRPC patients. Both drugs have distinct mechanisms of action and may have…”
Get full text
Journal Article -
17
Meta-analysis of randomized clinical trials (RCT) for the adjuvant treatment of high-risk clear cell renal carcinoma (RCC) with vascular endothelial growth factor receptor tyrosine-kinase inhibitors (VEGFR TKIs)
Published in Journal of clinical oncology (20-02-2018)“…Abstract only 660 Background: A significant proportion of RCC patients with localized disease will eventually recur after a curative intent nephrectomy. VEGFR…”
Get full text
Journal Article -
18
Precision medicine approach in kidney cancer: A pan renal cell carcinoma (RCC) study across three cancer genome atlas (TCGA) datasets for clinically relevant target identification
Published in Journal of clinical oncology (20-05-2015)“…Abstract only…”
Get full text
Journal Article -
19
Comprehensive genomic profiling to identify clinically relevant genomic alterations in patients with advanced penile cancers
Published in Journal of clinical oncology (20-05-2016)“…Abstract only…”
Get full text
Journal Article -
20
The impact of comprehensive genomic profiling in the management of patients with metastatic solid tumors in a developing country
Published in Journal of clinical oncology (20-05-2016)“…Abstract only…”
Get full text
Journal Article